Congestive Heart Failure (CHF) remains a leading cause of morbidity and mortality worldwide, with millions affected by its progressive and debilitating course. In his expert talk, Dr. Terrance Khastgir-an internationally recognized electrophysiologist-will present a cutting-edge overview of electrophysiology-based interventions in CHF, with a special focus on Cardiac Contractility Modulation (CCM) devices. Dr. Khastgir's session will explore the evolution of device therapies in heart failure management, from traditional pacemakers and ICDs to the latest innovations in CCM. Unlike conventional pacing, CCM delivers non-excitatory electrical signals during the absolute refractory period, enhancing myocardial contractility without altering heart rhythm. This therapy has shown significant improvements in exercise tolerance, quality of life, and left ventricular function in patients with reduced ejection fraction who are not candidates for CRT. Drawing from his extensive clinical and research experience, Dr. Khastgir will present data from trials that have shaped current guidelines, and ushered in a new era of precision electrophysiology. For clinicians, this talk offers a transformative lens on CHF management. CCM devices, once considered niche, are now redefining therapeutic possibilities for a subset of patients previously deemed refractory to standard care. Dr. Khastgir's insights will empower practitioners to integrate these technologies into practice, improving outcomes and expanding hope for patients with advanced heart failure.

Terrance Khastgir started his journey in medicine in India where he graduated from medical college with distinction and secured 3rd position in the University. He did his residency in Internal medicine from prestigious John’s Hopkins and Sinai Hospital program in Baltimore Maryland. As a resident he participated in research projects and worked under the supervision of Chief of Cardiology. He presented two papers in World Electrophysiology Conference held in Washington DC. He got the best resident award for his outstanding performance as resident. While he was working as a resident he was appointed as Clinical Instructor in Medicine at John’s Hopkins University. He joined University of Oklahoma to peruse his fellowship in cardiovascular medicine and Electrophysiology. During his training he continued to work under the supervision of faculty and published original papers and case reports. Upon graduation he joined Integris Baptist Medical Center which is a tertiary care center in Oklahoma City with robust cardiology services. He actively participated in research projects pertaining to device therapies including Leadless Pacemakers,ICDS BIVICDS ,Subcutaneous ICDS and Cardiac Contractility Modulation devices.He has been presenting his research work in various National and International Cardiology meetings. He has also worked as a consultant for several device companies. Over the years he has developed keen interest in device therapy for various cardiovascular diseases.